口咽癌经口机器人手术显微镜下阳性切缘全国分析
该研究基于美国国家癌症数据库2019年数据,回顾性分析4294例接受经口机器人手术的口咽癌患者,阳性切缘率为16.6%。HPV阴性鳞癌、涎腺癌、临床T分期、舌根原发及低容量非学术机构治疗与阳性切缘独立相关,阳性切缘与死亡率增加相关(aHR 1.67)。无淋巴结外侵犯的阳性切缘患者中,辅助放疗或放化疗较单纯手术改善总生存,但放化疗与放疗间无生存差异。
要点
- 口咽癌经口机器人手术阳性切缘率为16.6%,与HPV阴性鳞癌、涎腺癌、高T分期、舌根原发及低容量非学术机构相关。
- 阳性切缘与死亡风险增加独立相关(aHR 1.67,95%CI 1.40-1.99)。
- 无淋巴结外侵犯的阳性切缘患者中,辅助放疗或放化疗均较单纯手术改善总生存,但两者间无差异。
核心结论
- 组织学类型、临床T分期、肿瘤亚部位及低容量非学术机构治疗与经口机器人手术阳性切缘独立相关。
- 在整体队列及HPV相关或HPV阴性鳞癌无淋巴结外侵犯的阳性切缘患者中,辅助放化疗未较辅助放疗带来额外生存获益。
研究设计与样本
- 回顾性队列分析,数据来源于美国国家癌症数据库2019年患者用户文件。
- 纳入4294例年龄>18岁接受经口机器人手术切除的口咽癌患者,按切缘状态分层。
主要发现
- 阳性切缘率为16.6%。
- HPV阴性鳞状细胞癌、涎腺癌、临床T分期、舌根原发部位及低容量非学术机构治疗与阳性切缘独立相关。
- 阳性切缘与死亡率增加相关(aHR 1.67,95% CI:1.40-1.99)。
- 在无淋巴结外侵犯的阳性切缘患者中,辅助放疗(aHR 0.29,95% CI:0.19-0.45)和辅助放化疗(aHR 0.31,95% CI:0.21-0.45)较单纯手术改善总生存。
- 辅助放疗与辅助放化疗在HPV阳性和HPV阴性鳞癌患者中总生存相似。
关键数值与推荐
- 阳性切缘定义为显微镜下切缘阳性。
- 多变量逻辑回归用于识别与阳性切缘相关的临床变量,多变量Cox比例风险模型用于生存分析。
- 报告调整比值比(aOR)和风险比(aHR)及95%置信区间(CI)。
临床怎么用
- 对于口咽癌经口机器人手术,应关注HPV阴性鳞癌、涎腺癌、高临床T分期、舌根原发及低容量非学术机构治疗等阳性切缘风险因素。
- 阳性切缘患者术后需考虑辅助治疗以改善生存。
- 无淋巴结外侵犯的阳性切缘患者,辅助放疗可作为辅助放化疗的替代选择,避免过度治疗。
局限性
- 回顾性研究设计。
- 使用国家癌症数据库数据,可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to identify clinical variables associated with microscopic positive margins (PMs) during transoral robotic surgery (TORS) for oropharyngeal cancer (OPC) resection, and to explore the association of the receipt of adjuvant treatment with overall survival (OS) in this population. STUDY DESIGN: Retrospective cohort analysis. SETTING: 2019 Patient User File of the National Cancer Database. METHODS: Patients >18 years of age with OPC were stratified based on margin status. Multivariable logistic regression was used to identify clinical variables associated with PM. Survival analyses were performed using multivariable Cox proportional hazards models. Adjusted odds ratios (aORs) and hazard ratios (aHRs) with associated 95% confidence intervals (CIs) were generated. RESULTS: In total, 4294 patients met the criteria. The PM rate was 16.6%. Human papillomavirus (HPV)-negative squamous cell carcinoma (SCCa), salivary gland carcinoma, clinical T category, base of tongue primary site, and treatment at low-volume, nonacademic institutions were independently associated with PM. PMs were associated with increased mortality (aHR 1.67, 95% CI: 1.40-1.99). In patients with PM, but without extranodal extension (ENE), adjuvant radiation therapy (aRT) (aHR 0.29, 95% CI: 0.19-0.45) and adjuvant chemoradiotherapy (aCRT) (aHR 0.31, 95% CI: 0.21-0.45) were associated with an improvement in OS versus surgery alone; however, OS between aRT and aCRT was similar for both HPV-positive and HPV-negative SCCa. CONCLUSION: Histologic type, clinical T category, tumor subsite, and treatment at low-volume, nonacademic institutions were independently associated with TORS PM. aCRT did not confer a survival benefit over aRT in the overall cohort, or in subgroups of HPV-associated or HPV-negative SCCa patients with PM without ENE.
引用
- Tucker A, Bollig CA. A National Analysis of Microscopic Positive Margins in Oropharyngeal Cancer Patients Undergoing Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2026. PMID: 41582733. doi:10.1002/ohn.70100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。